03 Profile
Vital Signsby Bridgehead
Hansard to 11 November 2026 · 31,429 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Academic · Long Covid
Pablo Alvarez: no photograph is held, so the academic plate is shown instead.
Academic
Pablo Alvarez
co-first author of the study and a former graduate student in Li's lab
1
0
0
0
Aug 2026Sept 2026Oct 2026Nov 2026to date
1
press citation on 1 topic since 5 Aug 2026 · last quoted 5 Aug 2026
02 Quoted on · 1 of 29 topics
Pablo Alvarez: key facts
- Kind of voice
- Academic
- Role
- co-first author of the study and a former graduate student in Li's lab
- Quoted on
- Long Covid
- Tracked press citations
- 1
- Most recently quoted
- 5 Aug 2026
04 The signal · where Pablo Alvarez sits on long covid
Ranked 26= of 100 voices quoted in the press on long covid, level with 74 others on 1 citation.
Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.
- 1Professor Dmitry PshezhetskiyAcademicProfessorial Research Fellow, Norwich Medical School, University of East Anglia8
- 2=
Dr Charles ShepherdClinicianTrustee and Honorary Medical Adviser, The ME Association5 - 2=
Dr. Ewan HunterBusiness leaderChief Data Officer, Oxford BioDynamics Plc5 - 26=Marci LobelAcademicProfessor in the psychology department at Stony Brook University1
- 26=Melody LiAcademicassociate professor of microbiology, immunology and molecular genetics and member of the UCLA Broad Stem Cell Research Center1
- 26=Pablo AlvarezAcademicco-first author of the study and a former graduate student in Li's lab1
- 26=Zhenlan YaoAcademicco-first author of the study and a former postdoctoral researcher in Li's lab, who will soon begin a research assistant professorship at Hong Kong University1
- 26=Rob WüstAcademicmovement scientist at the VU1
Showing the leaders and the ranks around 26=, of 100 voices · See every voice on the topic →
05 On the record · press
What Pablo Alvarez has said
By outlet · linked articles
- newsroom.ucla.edu1
Where Pablo Alvarez has been quoted
- 01A lesser-known SARS-CoV-2 protein may offer clues to long COVID symptomsnewsroom.ucla.edu · 5 Aug 2026
Verbatim
“It's critical to keep studying COVID-19 so that we can constantly improve patient care — not everyone responds well to vaccines, and people who are immunocompromised often have limited treatment options. These studies can also help us prepare for future coronavirus outbreaks.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.